Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend
Mandate

Vinge advises Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend

May 30, 2013

Vinge has advised Djursjukhusgruppen in connection with the acquisition of Dyrekliniken på Stend, one of Norway’s largest veterinary clinics. A joint project is planned for the construction of a new veterinary hospital in Bergen. Djursjukhusgruppen is the Nordic region’s leading group of companies providing advanced veterinary care for dogs, cats and other pets.

Vinge’s team consisted of responsible partner Jonas Bergström together with, among others, associates Alexandra Kempe, Magnus Wieslander and Gustav Jönsson.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024